There is little consensus on the definition or optimal constituents of fluid bolus therapy (FBT), and there is uncertainty regarding its physiological effects. The aims of this study were to determine clinician-reported definitions of FBT and to explore the physiological responses clinicians expect from such FBT. In June and October 2014, intensive care and emergency physicians in Australia and New Zealand were asked to participate in an electronic questionnaire of the reported practice and expectations of FBT. Two hundred and fifty-one questionnaires were completed, 65.3% from intensivists. We identified the prototypical FBT given by intensivists is more than 250 ml of compound sodium lactate, saline or 4% albumin given in less than 30 minutes, while that given by emergency department physicians is a similar volume of saline delivered over a similar time frame. Intensive care and emergency physicians expected significantly different changes in mean arterial pressure (P=0.001) and heart rate (P=0.033) following FBT. Substantial variation was demonstrated in the magnitude of expected response within both specialties for each variable. Major variations exist in self-reported FBT practice, both within and between acute specialties, and wide variation can be demonstrated in the expected physiological responses to FBT. International explorations of practice and prospective quantification of the actual physiological response to FBT are warranted.
Key Words: fluid resuscitation, fluid bolus therapy, haemodynamic optimisation, critical care Fluid bolus therapy (FBT) is a standard of care in the management of the septic, hypotensive, tachycardic and/ or oliguric patient [1] [2] [3] [4] [5] [6] . Despite the recent publication of multiple highly visible randomised controlled trials examining different aspects of fluid administration in the critically ill [7] [8] [9] [10] [11] , there remains little consensus on what volume or rate of administration defines such FBT, or on which types of fluid are suitable for FBT 12 . Accordingly, such clinical decisions are based on influential historical observations and/or physiological reasoning [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . Three large, methodologically sound, harmonised, multicentre randomised controlled trials of early goal-directed therapy in patients with sepsis, of which aggressive FBT is a cornerstone, demonstrated no difference in mortality as a result of early goal-directed therapy [27] [28] [29] .
These complex findings have generated uncertainty about the quantity and quality of evidence supporting FBT, and doubt about the magnitude and duration of its physiological effects [30] [31] [32] .
We aimed to understand self-reported Australian and New Zealand FBT practice by conducting a survey of intensive care and emergency medicine specialists. Our objectives were to determine the self-reported definition of current FBT, and to explore the self-reported physiological response that clinicians expect from such FBT.
Methods

Ethics approval
This study was approved by both the local hospital (Human Research Ethics Committee Approval No.: LNR/14/ Austin/197) and the Monash University Research Ethics Committee (Project No.: CF14/2539-2014001354). Completion of the survey questionnaire was deemed to imply consent.
Survey design
We designed an electronic survey using a commercial web-based survey instrument (Survey Monkey, Palo Alto, CA, USA) using current literature on FBT. We aimed to produce a simple, unambiguous questionnaire that could be answered in less than 10 minutes while still providing us with comprehensive information about the volume, the rate of administration, and the types of fluids respondents felt were suitable for FBT, as well as the expected physiological response to such therapy.
Questionnaire
The questionnaire comprised two sections. The first section of the survey asked respondents to identify a) appropriate fluids for FBT, b) the minimum volume that constituted a fluid bolus, and c) the maximum amount of time they would allow for its delivery while still constituting FBT.
The second section contained six items; each item asked respondents to identify the minimum change in a specific haemodynamic variable that they believe constituted a response to FBT. These questions were designed to make it clear to the respondent that they were to be answered as if the decision to give the bolus had already been made.
Three senior intensivists and two senior emergency physicians reviewed the survey. Only minor changes to improve question readability were made. It was then piloted in a metropolitan, tertiary-level referral hospital before being distributed to the wider target population. The survey is included in the electronic supplemental material.
Respondents
The Australia and New Zealand Intensive Care Society Clinical Trials Group consists of 71 ICUs. All member units were approached and asked to invite their intensive care specialists to participate in this survey. An invitation was sent by email containing a hyperlink to the questionnaire. Participation was voluntary and anonymous. A two-week recruitment period was allocated for each specialty, and reminder emails sent during these periods to encourage participation. No such centralised mechanism for inviting emergency physicians to participate was available. Two of the authors used email distribution lists to invite emergency specialists across Australia and New Zealand to participate. An invitation was sent by email containing a hyperlink to the questionnaire. Participation was voluntary and anonymous.
Statistical methods
Responses were downloaded from the web-based survey provider into an MS Excel (Microsoft, Redmond, WA, USA) spreadsheet for storage and graphics creation. Statistical analyses were performed using STATA® version 13 (Stata Corp., College Station, TX, USA). Simple proportions and percentages were calculated, with the denominator being the number of respondents answering that section. Categorical variables were expressed as n (%). Results have been presented with an overall P-value between specialties along with specific pairwise comparisons of categories, with both calculated using Fisher's exact tests. Whilst a two-sided P-value of 0.05 was considered to be statistically significant for overall comparisons, to account for increased multiple testing for pairwise comparisons, a two-sided P-value of 0.01 was used to indicate statistical significance.
Results
Response rate and respondents
Overall, 251 fully completed questionnaires were returned. We obtained responses from 164 (65.3%) intensive care specialists between 16 
Defining FBT by fluid
All respondents completed this section of the survey. The majority (>80%) of both ICU and ED clinicians indicated that 0.9% saline and compound sodium lactate solution were suitable for FBT. Most intensivists (83%) would use Plasma-Lyte® (Baxter International, Deerfield, IL, USA) or similar solutions for FBT, while less than half (45%) of ED clinicians would (P <0.01). In addition, the majority of intensivists felt that 4% albumin solution was suitable for FBT, while the majority of ED physicians did not (93% versus 29%, P <0.01). Although one-third of intensivists felt 20% albumin could be used as FBT, significantly fewer ED specialists agreed (32% versus 13%, P <0.01). Moreover, 5% or less of either group of specialists would use 6% hydroxyethyl starch solution for FBT (Table 2, Figure 1 ).
Defining FBT by volume
Most respondents considered FBT to consist of volumes greater than 250 ml. With the exception of 20% albumin, where volumes ≥100 ml were thought to constitute FBT, for most colloid solutions 250 ml or more was thought to constitute FBT by similar proportions of both specialties (Table 3 ).
Significant differences were found in the distribution of responses between specialties with regard to the minimal acceptable volumes of compound sodium lactate (P=0.04), Plasma-Lyte (P <0.01) and 0.9% saline (P <0.01) believed to constitute FBT. Similarly, the volumes of gelatin solutions (P=0.01) and 4% albumin solution (P=0.02) thought to constitute FBT varied significantly between specialties (Table 3 ).
Maximum duration of administration to define FBT
Approximately 50% of both ICU and ED respondents reported that crystalloids should be administered in less than 10 minutes to constitute FBT. Cumulatively, more than 80% in each specialty believed crystalloid FBT should be delivered in less than 30 minutes. No significant differences were reported between groups (Tables 2 and 4 ).
Expected physiological response to FBT
Significant differences were found in the distribution of responses between specialties with regard to the minimal expected change in mean arterial pressure (P <0.01) and heart rate (P=0.03) constituting a response (Table 3 ). In contrast, both ICU and ED physicians expected similar changes in central venous pressure, urine output, central venous oxygen saturation, or blood lactate concentration. Substantial variation was demonstrated in the magnitude of expected response within both specialties for each haemodynamic variable. More than 50% of respondents expected a 10 to 20 ml/hour increase in urine output and a 4% to 8% increase in central venous oxygen saturation ( Table  5 , Table E1 in Electronic Supplemental Material). 
Discussion
Key findings
We surveyed a cohort of intensivists and emergency physicians in Australia and New Zealand to understand their self-reported views on FBT and the expected physiological response to FBT. We identified the prototypical FBT given to be more than 250 ml of crystalloid given in less than 30 minutes, with ICU but not ED physicians also turning to 4% albumin for FBT. However, we found major variations in self-reported FBT practice, both within and between these acute care specialties and wide variation within and across specialties in the expected physiological responses to FBT.
Relationship with previous studies
In 2007, a cross-sectional survey of patients receiving fluid resuscitation in 391 ICUs in 25 countries 33 found that more than 50% of patients received FBT on the day of their admission, with more than 30% still receiving FBT at day 6. Starches, 4% albumin and gelatins were used more frequently than crystalloids and the type of fluid administered had a stronger relationship with the country rather than with any demographic or clinical feature of the patient. In that survey, Australian patients were more likely to receive colloid than crystalloid FBT, while in New Zealand the opposite held true. Australian patients were equally as likely to receive gelatin as 4% albumin, while in New Zealand, the most common colloids administered were starch solutions. No information regarding resuscitation volumes, rate of administration, or expectations of therapy were recorded. To the best of our knowledge, there are no similar studies in the setting of the emergency department.
In a recent systematic review, no contemporary studies comparing the effects of FBT to appropriately defined control groups were identified 12 . Thus, the independent effects of FBT in critically ill patients are unknown. An Australian uncontrolled single-centre study demonstrated a modest average increase in central venous pressure and a significant worsening of the ratio of arterial oxygen partial pressure to fractional inspired oxygen 60 minutes after FBT of varying amounts of predominantly 4% albumin 34 . No other haemodynamic index improved significantly. This is despite the treating clinician believing that a successful response to FBT had occurred in 29.7% to 79.4% of cases, depending on the reason for initiating FBT. Such findings support the variance in the expected physiological response to FBT demonstrated by our cohort. To the best of our knowledge, this is the first study to report on the kind of haemodynamic changes that ICU and ED clinicians expect with FBT.
Study implications
The findings of this survey demonstrate marked variation in fluid type, volume and rate of administration for FBT in Australia and New Zealand and major variation in the expected physiological response to such therapy. Our results suggest an urgent need for higher quality studies of the effect of FBT, as defined in this study, on key physiological parameters to establish whether clinician expectations are accurate.
Study strengths and limitations
This study has several strengths. To our knowledge, it is the first study to document self-reported FBT practice in Australia and New Zealand. Second, it is the first to document the physiological response that clinicians expect from FBT. We demonstrate that such expectations appear divorced from the responses described in the literature. Third, our survey allowed us to define the characteristics and expectation of a prototypical FBT according to two key specialties involved in its administration. Fourth, we subjected our survey to a robust assessment pre-release, using both expert review, and a piloted trial.
This study has some limitations. First, as a survey of selfreported practice, our results do not necessarily represent actual practice, which may vary for numerous and complex reasons. However, both critical care and emergency medicine are well-established specialties in Australia and New Zealand, with standardised training programs and examinations. This suggests a uniformity of baseline competence and may limit extremes of practice. Second, we cannot impute an appropriate denominator to calculate a response rate. However, given the responses involved 250 clinicians, we consider that they are likely to be somewhat representative of the larger population of Australian and New Zealand acute care specialists. Finally, our findings may not apply to other countries. As such, multi-national cohort investigations into the self-reported and actual practice of FBT are warranted.
Conclusion
This survey provides the first self-reported account of FBT acute practice in Australia and New Zealand. FBT remains a poorly defined intervention with considerable variability in preferred fluid choice, volume given and speed of delivery. Moreover, both intensive care and emergency medicine specialists have uncertain physiological expectations of FBT. Our results justify an exploration of self-reported international practice and the conduct of prospective studies to accurately document the actual physiological response to a standardised FBT.
